Dorchester Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,072
Closed -$547K 159
2024
Q3
$547K Buy
6,072
+175
+3% +$14.7K 0.1% 92
2024
Q2
$464K Buy
5,897
+242
+4% +$19.8K 0.09% 100
2024
Q1
$493K Buy
5,655
+850
+18% +$72.5K 0.09% 110
2023
Q4
$396K Buy
4,805
+152
+3% +$11.6K 0.07% 113
2023
Q3
$365K Buy
4,653
+150
+3% +$12.6K 0.07% 115
2023
Q2
$397K Buy
4,503
+1,220
+37% +$105K 0.08% 108
2023
Q1
$265K Buy
3,283
+164
+5% +$13.4K 0.05% 131
2022
Q4
$242K Buy
3,119
+215
+7% +$17.4K 0.06% 129
2022
Q3
$234K Hold
2,904
0.05% 134
2022
Q2
$261K Buy
2,904
+990
+52% +$100K 0.05% 131
2022
Q1
$265K Buy
+1,914
New +$202K 0.04% 139
2021
Q4
Sell
-1,841
Closed -$231K 155
2021
Q3
$231K Sell
1,841
-507
-22% -$65.6K 0.06% 131
2021
Q2
$291K Buy
2,348
+18
+0.8% +$2.26K 0.07% 130
2021
Q1
$275K Buy
2,330
+463
+25% +$54.3K 0.07% 124
2020
Q4
$219K Buy
+1,867
New +$206K 0.06% 132
2020
Q1
Sell
-2,162
Closed -$245K 127
2019
Q4
$245K Buy
2,162
+114
+6% +$12.5K 0.07% 110
2019
Q3
$222K Buy
+2,048
New +$214K 0.07% 114

Other funds holding MDT

Dorchester Wealth Management's MDT Position: Q4 2024 in Review

Dorchester Wealth Management sold out of Medtronic (MDT) in Q4 2024, closing a stake of 6,072 shares — an estimated $547K sold.

Dorchester Wealth Management first reported a position in MDT in Q3 2019 and held it in 17 quarters. The position peaked at $547K in Q3 2024. 2,123 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Dorchester Wealth Management reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Dorchester Wealth Management sold 6,072 Medtronic shares in Q4 2024, an estimated $547K.
  • Dorchester Wealth Management first reported a position in Medtronic in Q3 2019 and held it in 17 quarters.
  • Dorchester Wealth Management's Medtronic position peaked at $547K in Q3 2024.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Dorchester Wealth Management's 13F filing for Q4 2024, filed 4 Feb 2025.